• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮患者的持续炎症-免疫抑制-分解代谢综合征。

Persistent inflammation-immunosuppression-catabolism syndrome in patients with systemic lupus erythematosus.

机构信息

National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing, 210016, Jiangsu, China.

出版信息

Int Urol Nephrol. 2023 Jul;55(7):1757-1765. doi: 10.1007/s11255-023-03479-3. Epub 2023 Feb 5.

DOI:10.1007/s11255-023-03479-3
PMID:36739569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9899504/
Abstract

OBJECTIVE

To evaluate the clinical characteristics and prognosis of systemic lupus erythematosus (SLE) with persistent inflammation-immunosuppression-catabolism syndrome (PICS).

METHODS

We retrospectively analyzed patients with SLE who were admitted to the renal intensive care unit (ICU) for over 14 days at Jinling Hospital from July 2010 to July 2018. According to the diagnostic criteria of PICS, we divided the SLE patients into a PICS group and a non-PICS group. We performed a multivariate Cox regression analysis on the risk factors for death in these two groups by comparing the clinical features and prognosis.

RESULTS

A total of 96 SLE patients met the inclusion and exclusion criteria of this study, including 61 patients in the PICS group and 35 patients in the non-PICS group. The PICS group patients required a longer length of stay in ICU with higher inflammatory indicators (such as C-reactive protein, procalcitonin and interleukin-6) and lower immune levels (such as total, CD3 + , CD4 + , CD8 + and CD20 + lymphocytes) compared to the non-PICS group patients (P < 0.01). Hemoglobin, platelets, serum creatinine, serum blood urea nitrogen and SLE Disease Activity Index (SLE-DAI) score in the PICS group were lower than those in the non-PICS group (P < 0.05), suggesting severe hematological injury in the PICS group and relatively severe renal damage in the non-PICS group. The rates of PICS combined with sepsis, acute respiratory distress syndrome, mechanical ventilation, gram-positive bacteria, gram-negative bacteria, fungi and double infections were higher than those in the non-PICS group (P < 0.05). The 3-year survival rate was 50.82% in the PICS group and 85.71% in the non-PICS group. The 3-year renal survival rate was 32.79% in the PICS group and 51.43% in the non-PICS group. Multivariate Cox regression found that the total lymphocyte count during ICU admission was an independent risk factor for death in SLE patients with PICS.

CONCLUSION

Patients with SLE complicated with PICS had longer ICU stays, a lower level of SLE activity, a higher risk of secondary infection and a significantly lower survival rate than non-PICS patients.

摘要

目的

评估持续炎症-免疫抑制-消耗综合征(PICS)的系统性红斑狼疮(SLE)的临床特征和预后。

方法

我们回顾性分析了 2010 年 7 月至 2018 年 7 月在南京金陵医院肾重症监护病房(ICU)住院超过 14 天的 SLE 患者。根据 PICS 的诊断标准,我们将 SLE 患者分为 PICS 组和非 PICS 组。通过比较两组的临床特征和预后,对两组患者死亡的危险因素进行多变量 Cox 回归分析。

结果

共纳入 96 例 SLE 患者,其中 61 例为 PICS 组,35 例为非 PICS 组。与非 PICS 组相比,PICS 组患者 ICU 住院时间更长,炎症指标(如 C 反应蛋白、降钙素原和白细胞介素 6)更高,免疫水平(如总淋巴细胞、CD3+、CD4+、CD8+和 CD20+淋巴细胞)更低(P<0.01)。PICS 组血红蛋白、血小板、血清肌酐、血清尿素氮和 SLE 疾病活动指数(SLE-DAI)评分均低于非 PICS 组(P<0.05),提示 PICS 组存在严重的血液学损伤,而非 PICS 组存在相对严重的肾脏损伤。PICS 组合并脓毒症、急性呼吸窘迫综合征、机械通气、革兰阳性菌、革兰阴性菌、真菌和双重感染的发生率高于非 PICS 组(P<0.05)。PICS 组 3 年生存率为 50.82%,非 PICS 组为 85.71%。PICS 组 3 年肾脏生存率为 32.79%,非 PICS 组为 51.43%。多变量 Cox 回归发现,ICU 住院期间总淋巴细胞计数是 PICS 患者死亡的独立危险因素。

结论

与非 PICS 患者相比,SLE 合并 PICS 的患者 ICU 住院时间更长,SLE 活动水平更低,继发感染风险更高,生存率显著降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a30f/9899504/1fd094cb4a66/11255_2023_3479_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a30f/9899504/1ca6871cf052/11255_2023_3479_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a30f/9899504/1fd094cb4a66/11255_2023_3479_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a30f/9899504/1ca6871cf052/11255_2023_3479_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a30f/9899504/1fd094cb4a66/11255_2023_3479_Fig2_HTML.jpg

相似文献

1
Persistent inflammation-immunosuppression-catabolism syndrome in patients with systemic lupus erythematosus.系统性红斑狼疮患者的持续炎症-免疫抑制-分解代谢综合征。
Int Urol Nephrol. 2023 Jul;55(7):1757-1765. doi: 10.1007/s11255-023-03479-3. Epub 2023 Feb 5.
2
[Analysis of the risk factors of persistent inflammation-immunosuppression-catabolism syndrome in patients with extensive burns].[大面积烧伤患者持续性炎症-免疫抑制-分解代谢综合征的危险因素分析]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Apr 20;39(4):350-355. doi: 10.3760/cma.j.cn501225-20220214-00028.
3
[Predictive value of glycosylated serum protein combined with glycemic variability on secondary persistent inflammatory immunosuppressed catabolic syndrome prediction in elderly septic patients].糖化血清蛋白联合血糖变异性对老年脓毒症患者继发性持续性炎症免疫抑制分解代谢综合征预测的价值
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1051-1055. doi: 10.3760/cma.j.issn.2095-4352.2018.011.008.
4
CLINICAL AND PROGNOSTIC FEATURES OF CHRONIC CRITICAL ILLNESS/PERSISTENT INFLAMMATION IMMUNOSUPPRESSION AND CATABOLISM PATIENTS: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY.慢性危重病/持续性炎症免疫抑制和分解代谢患者的临床及预后特征:一项前瞻性观察性临床研究
Shock. 2023 Jan 1;59(1):5-11. doi: 10.1097/SHK.0000000000002035. Epub 2022 Nov 17.
5
Persistent inflammation-immunosuppression catabolism syndrome, a common manifestation of patients with enterocutaneous fistula in intensive care unit.持续炎症-免疫抑制-分解代谢综合征,是重症监护病房肠外瘘患者的常见表现。
J Trauma Acute Care Surg. 2014 Mar;76(3):725-9. doi: 10.1097/TA.0b013e3182aafe6b.
6
[A retrospective clinical study of sixty-three cases with persistent inflammation immunosuppression and catabolism syndrome].[63例持续性炎症免疫抑制和分解代谢综合征的回顾性临床研究]
Zhonghua Nei Ke Za Zhi. 2016 Dec 1;55(12):941-944. doi: 10.3760/cma.j.issn.0578-1426.2016.12.007.
7
Outcome of critically ill patients with systemic lupus erythematosus from a medical intensive care unit in Southern India.印度南部一家重症监护病房系统性红斑狼疮危重症患者的结局。
Lupus. 2023 Oct;32(12):1462-1470. doi: 10.1177/09612033231204074. Epub 2023 Sep 28.
8
Incidence and variables associated with short and long-term mortality in patients with systemic lupus erythematosus and sepsis admitted in intensive care units.入住重症监护病房的系统性红斑狼疮合并脓毒症患者短期和长期死亡率的发生率及相关变量。
Lupus. 2018 Oct;27(12):1936-1943. doi: 10.1177/0961203318796288. Epub 2018 Sep 5.
9
Early Prediction for Persistent Inflammation-Immunosuppression Catabolism Syndrome in Surgical Sepsis Patients.外科脓毒症患者持续性炎症-免疫抑制-分解代谢综合征的早期预测
Int J Gen Med. 2021 Sep 9;14:5441-5448. doi: 10.2147/IJGM.S331411. eCollection 2021.
10
The long-term quality of life in patients with persistent inflammation-immunosuppression and catabolism syndrome after severe acute pancreatitis: A retrospective cohort study.持续性炎症-免疫抑制和分解代谢综合征患者在重症急性胰腺炎后的长期生活质量:一项回顾性队列研究。
J Crit Care. 2017 Dec;42:101-106. doi: 10.1016/j.jcrc.2017.07.013. Epub 2017 Jul 8.

引用本文的文献

1
Risk factors, biomarkers, and mechanisms for persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a systematic review and meta-analysis.持续炎症、免疫抑制和分解代谢综合征(PICS)的风险因素、生物标志物和机制:系统评价和荟萃分析。
Br J Anaesth. 2024 Sep;133(3):538-549. doi: 10.1016/j.bja.2024.03.038. Epub 2024 Apr 30.
2
Development and validation of a nomogram for predicting persistent inflammation, immunosuppression, and catabolism syndrome in trauma patients.创伤患者持续性炎症、免疫抑制和分解代谢综合征预测列线图的开发与验证
Front Med (Lausanne). 2023 Aug 24;10:1249724. doi: 10.3389/fmed.2023.1249724. eCollection 2023.

本文引用的文献

1
Long-term follow-up of autologous peripheral blood hematopoietic stem cell transplantation for refractory lupus nephritis-a series study of 20 patients.自体外周血造血干细胞移植治疗难治性狼疮肾炎的长期随访——20 例系列研究
Lupus. 2022 Nov;31(13):1586-1594. doi: 10.1177/09612033221126848. Epub 2022 Sep 17.
2
Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.免疫监测方法在脓毒症免疫抑制中的研究进展。
Front Immunol. 2022 May 10;13:891024. doi: 10.3389/fimmu.2022.891024. eCollection 2022.
3
Early Prediction for Persistent Inflammation-Immunosuppression Catabolism Syndrome in Surgical Sepsis Patients.
外科脓毒症患者持续性炎症-免疫抑制-分解代谢综合征的早期预测
Int J Gen Med. 2021 Sep 9;14:5441-5448. doi: 10.2147/IJGM.S331411. eCollection 2021.
4
Global epidemiology of systemic lupus erythematosus.系统性红斑狼疮的全球流行病学。
Nat Rev Rheumatol. 2021 Sep;17(9):515-532. doi: 10.1038/s41584-021-00668-1. Epub 2021 Aug 3.
5
Chronic Critical Illness and PICS Nutritional Strategies.慢性危重病与危重症后综合征营养策略
J Clin Med. 2021 May 25;10(11):2294. doi: 10.3390/jcm10112294.
6
All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study.系统性红斑狼疮的全因和病因特异性死亡率:一项基于人群的研究。
Rheumatology (Oxford). 2021 Dec 24;61(1):367-376. doi: 10.1093/rheumatology/keab362.
7
Inflammatory markers in systemic lupus erythematosus.系统性红斑狼疮中的炎症标志物。
J Autoimmun. 2020 Jun;110:102374. doi: 10.1016/j.jaut.2019.102374. Epub 2019 Dec 4.
8
Individualizing Therapy in Lupus Nephritis.狼疮性肾炎的个体化治疗
Kidney Int Rep. 2019 Aug 20;4(10):1366-1372. doi: 10.1016/j.ekir.2019.08.005. eCollection 2019 Oct.
9
Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis.自体造血干细胞移植治疗难治性狼疮肾炎。
Clin J Am Soc Nephrol. 2019 May 7;14(5):719-727. doi: 10.2215/CJN.10570918. Epub 2019 Apr 12.
10
Improvement of Outcomes in Patients with Lupus Nephritis: Management Evolution in Chinese Patients from 1994 to 2010.狼疮肾炎患者结局的改善:1994 年至 2010 年中国患者的治疗演变。
J Rheumatol. 2019 Aug;46(8):912-919. doi: 10.3899/jrheum.180145. Epub 2019 Mar 1.